The Global Antimicrobial Susceptibility Testing Market size is projected to reach USD X.XX billion by 2028, at a CAGR of 5.7% during the forecast period from 2021-2028. The demand for automated antimicrobial susceptibility testers will escalate in the coming years owing to its benefits such as reduced turnaround time and improved accuracy rates. People all over the world are investing in Global Antimicrobial Susceptibility Tester Market because it has huge potential to grow with an increasing number of patients diagnosed with resistant bacterial infections every year due to improper use of antibiotics and other factors that contribute towards drug resistance development.
Antimicrobial Susceptibility Testing (AST) is a laboratory procedure in which bacteria are grown in the presence of varying amounts of antibiotics to determine how they react. This test can be used as follow-up tests for patients with suspected bacterial infections or those who have been prescribed certain types of antibiotics, such as beta-lactams and fluoroquinolones, to find out if an infection has become resistant to these drugs. Antimicrobial susceptibility testing will help doctors prescribe more effective treatments by making sure that the right drug is given at the right dose so it cannot evolve into gentamicin resistance as other strains do. Here are some examples where ASTs would be useful: A patient develops a fever after being bitten by a dog that has a history of rabies and the doctor is thinking about prescribing an antibiotic. A patient with cystic fibrosis develops lung infections, so they are prescribed antibiotics to fight bacteria in their lungs. Patients with end-stage heart failure who have been found to be allergic to certain beta-blockers will need regular blood tests for bacterial growth caused by infection. An HIV-positive person taking PEP (post-exposure prophylaxis) needs testing twice per day during treatment because it only lasts 28 days or three weeks.
On the basis of Type, the global antimicrobial susceptibility testing market is segmented into automatic antimicrobial susceptibility testers and manual antimicrobial susceptibility testers.
Automatic antimicrobial susceptibility testers are devices that provide quick, accurate, and reliable results. These devices run a battery of tests simultaneously and transmit the results back to a central location. They are mainly used in hospitals, clinics, or reference laboratories for accurate antibiotic susceptibility testing. Automatic antimicrobial susceptibility testers offer features like real-time monitoring and control of the entire process, automation to reduce operator involvement, a shorter turnaround time for results, reduced risk of cross-contamination. They are mainly used in hospitals or clinics where infection rates can be as high as 30%.
Manual antimicrobial susceptibility testers are devices that determine the sensitivity of certain bacteria to a given antibiotic by observing color changes in bacterial cultures. The manual system is less advanced than automatic systems, but it provides an estimate for treatment and may be used when there is no physical access to the equipment needed for testing or if the patient has an infection with resistant organisms. Manual testers usually involve combining disks with different antibiotics and observing their effect on microbes in a petri dish. The result is recorded as clear, intermediate, resistant, or no reaction at all.
On the basis of Application, the global antimicrobial susceptibility testing market is segmented into hospital, clinic, others.
In hospitals, antimicrobial susceptibility tests are mainly conducted in respiratory tract infections and wound-related infections. The test determines which antibiotics would be effective for the specific infection based on its sensitivity profile with respect to different classes of drug molecules. This helps doctors decide what course of treatment is best for each patient’s condition. For example, if the bacteria has decreased or no response to penicillin then other antibiotics will need to be prescribed such as cephalosporins and aminoglycosides because these drugs have higher success rates against non-penicillin-resistant staphylococcus species (NAPRS).
In the clinic, antimicrobial susceptibility testing is used to determine the effectiveness of an antibiotic agent against a specific bacterial strain. The test process usually involves taking a sample from the patient's infected site and mixing it with different antibiotics until one is found that successfully kills all bacteria. This information can be used for guiding therapy in sepsis management as well as preventing resistance through judicious selection of antimicrobials. It also helps healthcare practitioners plan better treatments by providing important insights into infection mechanisms not only at the individual microbial level but also across populations.
On the basis of Region, the global antimicrobial susceptibility testing market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for more than one-third share of the global market in 2018 owing to the presence of an advanced healthcare system in this region which has resulted in an increased adoption rate by clinicians as well as patients. Europe followed the North American region with a significant contribution from countries such as Germany and UK due to their high GDP per capita rates and aging population combined with increasing consumption pattern favoring antibiotics on an outpatient basis over traditional medicines option like herbal products or treatments involving physical therapy. The Asia Pacific is anticipated to witness the fastest growth during the forecast period owing to the rapidly expanding middle-class population base coupled with the huge unmet demand for antibiotics among people with limited access to healthcare facilities.
The rise in the incidence of antimicrobial resistance (AMR) is a major factor contributing to the growth of the global antimicrobial susceptibility testing market. Antimicrobials are used for the prevention, treatment, or elimination of infectious agents that cause diseases such as fever, chills, nausea, etc., which cannot be prevented without them. Presently most infections can be cured with antibiotics but this may not always remain so if present trends continue unchecked according to experts. The emergence of new and rapidly evolving micro-organisms is another major factor contributing to the growth in the global antimicrobial susceptibility testing market. These superbugs are resistant to most antibiotics which have led them to become a public health concern for healthcare facilities, pharmaceutical companies, as well as governments around the world according to various studies published in leading medical journals such as The Lancet Infectious Diseases Journal.
Up Market Research published a new report titled “Antimicrobial Susceptibility Tester Market research report which is segmented by Types (Automatic Antimicrobial Susceptibility Tester, Manual Antimicrobial Susceptibility Tester), By Applications (Hospital, Clinic, Others), By Players/Companies Danaher, ThermoFisher Scientific, HiMedia Laboratories, BD, Creative Diagnostics, MERLIN Diagnostika, Alifax, Bioanalyse, Compagnie Merieux Alliance”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Antimicrobial Susceptibility Tester Market Research Report |
By Type | Automatic Antimicrobial Susceptibility Tester, Manual Antimicrobial Susceptibility Tester |
By Application | Hospital, Clinic, Others |
By Companies | Danaher, ThermoFisher Scientific, HiMedia Laboratories, BD, Creative Diagnostics, MERLIN Diagnostika, Alifax, Bioanalyse, Compagnie Merieux Alliance |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 215 |
Number of Tables & Figures | 151 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Automatic Antimicrobial Susceptibility Tester, Manual Antimicrobial Susceptibility Tester and By Application Hospital, Clinic, Others.
Some of the companies that are profiled in this report are:
Antimicrobial Susceptibility Tester Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Antimicrobial Susceptibility Tester Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Antimicrobial Susceptibility Tester Market Report:
Some other reports from this category!